Help us spreading the word about the joint Cytokines & ILC4 2022 meeting!
Join the #Cytokines2022 trend and follow us on social media, retweet our posts!
Feel free to use these banners on your website, on your events calendar and in your email signature.
Banner 728 x 90 px
Banner 1250 x 200 px
Banner 160 x 600 px
Square for sponsors
Twitter banner Cytokines 2022
Twitter banner ILC4
CYTOKINE OHANA: BRIDGING PHYSIOLOGICAL SYSTEMS
Join us in Hawaii for the joint meeting of the International Cytokines & Interferon Society and 4th International Conference on Innate Lymphoid Cells.
Date: 20-23 September 2023
Venue: Hilton Waikoloa Village, Hawaii, USA
This meeting annually attracts 700-1,000 of the world’s leading experts in immunology, rheumatology, infectious disease, cancer and inflammation and covers fundamental, translational and clinical, cutting-edge updates on cytokine-based therapeutics and immune-modifying biologics to treat cancer, autoimmunity, infectious disease (including COVID-19), and vaccine applications. Many of the major advances in cytokine biology were first reported at this annual conference, and we very much look forward to continuing this strong tradition in Hawaii.
ILCS IN TISSUE HOMEOSTASIS AND DISEASE
in tissue homeostasis and diseaseThe 4th International Conference on Innate Lymphoid Cells (ILC4)
https://ilc2020.org was originally scheduled to take place in October, 2020 in San Francisco. The meeting was postponed due to the COVID-19 pandemic and is now being planned as a joint meeting with Cytokines 2022 Hybrid. Registered attendees of one meeting may participate in sessions of the other, and there will be a few combined sessions and social functions, but the ILC4 program will focus on ILC’s and be just as diverse and comprehensive as the previous three meetings have been.The theme of ILC4 is ILCs in tissue homeostasis and disease. The aim of this international conference series is to provide an interactive platform for the exchange of new concepts, ideas and data between immunologists interested in ILCs and innate lymphocytes at large. ILCs are recently described tissue-resident cells increasingly implicated across a spectrum of diseases, including in humans. New methods, some rapidly evolving, have enabled a deeper look at the role of these cells in tissue health. Unappreciated plasticity, migration and functions are being uncovered every day, necessitating a timely update of standard methods, technologies and functional assays required for purification, imaging and analysis of ILCs with unprecedented detail, including single-cell sequencing and multi-parameter protein-based approaches. Attendees will learn the state-of-the-art current understanding of these fascinating cells from world experts in all facets of their biology.